168 related articles for article (PubMed ID: 9791040)
1. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.
Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM
Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.
Richards AM; Crozier IG; Yandle TG; Espiner EA; Ikram H; Nicholls MG
Br Heart J; 1993 May; 69(5):414-7. PubMed ID: 8390847
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
5. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.
Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ
Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715
[TBL] [Abstract][Full Text] [Related]
8. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
9. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
10. Endopeptidase inhibition in angiotensin-induced hypertension. Effect of SCH 39370 in sheep.
Charles CJ; Espiner EA; Richards AM; Sybertz EJ
Hypertension; 1995 Jul; 26(1):89-94. PubMed ID: 7607738
[TBL] [Abstract][Full Text] [Related]
11. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
[TBL] [Abstract][Full Text] [Related]
12. Plasma alpha natriuretic peptide in cardiac impairment.
Richards AM; Cleland JG; Tonolo G; McIntyre GD; Leckie BJ; Dargie HJ; Ball SG; Robertson JI
Br Med J (Clin Res Ed); 1986 Aug; 293(6544):409-12. PubMed ID: 2943356
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
[TBL] [Abstract][Full Text] [Related]
14. Plasma neuropeptide Y and atrial natriuretic peptide concentrations in man.
Russell AE; Aylward PE; Smith SA; Cain MD; McRitchie RJ; Chalmers JP
Clin Exp Pharmacol Physiol; 1988 Dec; 15(12):955-8. PubMed ID: 2977307
[TBL] [Abstract][Full Text] [Related]
15. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism.
Lang CC; Motwani JG; Coutie WJ; Struthers AD
Clin Sci (Lond); 1992 Jun; 82(6):619-23. PubMed ID: 1320540
[TBL] [Abstract][Full Text] [Related]
16. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
17. Low-dose brain natriuretic peptide infusion in normal men and the influence of endopeptidase inhibition.
Florkowski CM; Richards AM; Espiner EA; Yandle TG; Sybertz E; Frampton CM
Clin Sci (Lond); 1997 Mar; 92(3):255-60. PubMed ID: 9093005
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Lainchbury JG; Richards AM; Nicholls MG; Espiner EA; Yandle TG
J Clin Endocrinol Metab; 1999 Feb; 84(2):723-9. PubMed ID: 10022444
[TBL] [Abstract][Full Text] [Related]
19. Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
Richards AM; Crozier IG; Espiner EA; Yandle TG; Nicholls MG
Hypertension; 1993 Aug; 22(2):231-6. PubMed ID: 8340158
[TBL] [Abstract][Full Text] [Related]
20. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
